Place of birth | Sensitive to isoniazid and rifampicin | Resistant to isoniazid and sensitive to rifampicin | Multidrug resistant | |||
Total n | In cluster n (% of total) | Total n | In cluster n (% of total) | Total n | In cluster n (% of total) | |
Norway | 372 | 63 (17) | 6 | 3 (50) | 2 | 0 (0) |
Europe | 58 | 14 (24) | 2 | 0 (0) | 1 | 1 (100) |
Asia | 144 | 6 (4) | 14 | 1 (7) | 1 | 1 (100) |
Africa | 121 | 25 (21) | 22 | 12 (55) | 6 | 6 (100) |
Total | 703# | 108 (15) | 44 | 16 (36) | 10 | 8 (80) |
Only patients with strains with five or more IS6110 copies in restriction fragment length polymorphism analysis are included
#: including six cases from the Americas and two with unknown foreign place of birth